Autonomix Medical (AMIX) news
Recent news
Autonomix Medical expands intellectual property portfolio with new U.S. patent covering feedback-guided precision neuromodulation and targeted therapy delivery
Autonomix Medical Inc. has been granted a new U.S. patent covering feedback-guided precision neuromodulation and targeted therapy delivery, further expanding its intellectual property portfolio [1]. The patent, issued by the United States Patent and Trademark Office, relates to technologies…
AInvest Wire · 5d agoAutonomix Medical - regains Nasdaq bid price rule compliance as of July 9, 2026 - SEC filing
AInvest Wire · Jul 10, 2026Autonomix announces reverse stock split
AInvest Wire · Jun 18, 2026Autonomix Medical announces release of new CEO Corner segment highlighting global scientific and clinical recognition of platform technology
AInvest Wire · Jun 10, 2026ImportantAutonomix Medical Shares Rise 13% After Site Initiation for Clinical Study
Autonomix Medical Shares Rise 13% After Site Initiation for Clinical Study Autonomix Medical, a biotech firm focusing on diabetes treatment, recently announced a 13% rise in its shares following the initiation of a clinical study at one of its sites [1]. This development comes as welcome news to…
AInvest Wire · Feb 16, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.